Latest COX-2 inhibitor Stories
EUGENE, Ore., Nov. 19, 2014 /PRNewswire/ -- As the calendar page has turned to November, the typical American is making more frequent trips to the medicine cabinet.
MISSISSAUGA, ON, Sept. 8, 2014 /PRNewswire/ - Nuvo Research Inc.
Researchers in Australia say aspirin may temporarily stave off mesothelioma in asbestos-exposed mice, but will not keep the disease from developing. Raleigh,
New Indication in Chronic Pain Marks Company's Third FDA Approval in Less Than a Year PHILADELPHIA, Aug.
MISSISSAUGA, ON, May 29, 2014 /PRNewswire/ - Nuvo Research Inc.
DUBLIN, April 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that its subsidiary, Watson Laboratories, Inc., has filed suit against the U.S.
Mylan Seeks to Confirm Shared 180-Day Exclusivity PITTSBURGH, April 25, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has filed suit against the U.S.
The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks: lowering colon cancer risk among people with high levels of a specific type of gene.
DUBLIN, April 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Pfizer, Inc.